Presented by: Jake Morgan, PhD
Presentation title: Expanding the Impact of Substance Use Disorder Research: Economic Analysis for Program and Policy Evaluation
This overview training is for researchers who wish to improve their understanding of economic analysis such that you can attend conference presentations or read peer-reviewed articles and comfortably interpret overall conclusions. This training will provide an overview, application, and interpretation of health economics techniques—including cost-effectiveness and cost-benefit analysis—and will use examples from the literature related to HIV, HCV, and substance use disorder.
This training is supported by The Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH: P30DA040500), a NIDA-funded National Center of Excellence.
Jake Morgan is a Research Assistant Professor in the Department of Health Law, Policy, and Management at the Boston University School of Public Health. Dr. Morgan is an applied health economist with extensive experience in statistical, econometric, and simulation modeling approaches. He has a history of collaborating with public health stakeholders and excels at leveraging real-world big data to answer pressing public health questions. Dr. Morgan is an investigator in CHERISH’s HCV and HIV Core has worked with CHERISH since its inception.
Presented by: Holly Hagan, PhD & Sam Friedman, PhD
Presentation title: Fruitful Areas of Funding for Research on HIV, HCV and Other Health Issues among Drug Using Populations
Holly Hagan and Sam Friedman will discuss promising areas for funding of research on HIV and HCV among people who use drugs. They will review the NIH strategic plan for HIV-related research, as well as NIDA’s funding priorities. They will also discuss investigator-initiated research that blends and expands the priorities.
We encourage participants to send their research ideas in advance to CDUHR@nyu.edu. Drs. Hagan and Friedman will provide feedback on these ideas at the workshop. Participants may also bring their ideas to the workshop.
Holly Hagan is the director of CDUHR. She is trained as an infectious disease epidemiologist with an emphasis on methods to study disease causation and control. Dr. Hagan is an internationally-recognized expert in the etiology, epidemiology, natural history, prevention and treatment of hepatitis C virus infection among people who use drugs, and in 2014 her work was recognized by the US Department of Health and Human Services with the President’s Award for Leadership in the Control of Viral Hepatitis in the United States. Dr. Hagan served on the Institute of Medicine Committee on the Prevention and Control of Viral Hepatitis in the United States, and she has been an advisor to the US Department of Health and Human Services, the CDC, and the Canadian Institutes of Health on national programs to detect, diagnose and treat HCV infections. She was selected by NIDA to chair the Executive Steering Committee for the Rural Opioid Initiative funded by NIH, CDC, SAMHSA and the Appalachian Regional Commission. She was recently appointed to the National Academy of Medicine Committee on the Examination of the Integration of Opioid and Infectious Disease Prevention Efforts in Select Programs.
Sam Friedman is an associate director of the Infectious Disease Epidemiology and Theory Core. Dr. Friedman has worked on research concerning people who use drugs and HIV since 1983. He has written widely on related epidemiology and prevention topics. His work has contributed substantially to what we know about drug users’ social networks and their relations to HIV epidemics; to our understanding of macro-social epidemiology of drug use and its associated diseases; to the theory and practice of drug users’ organizations and their efforts to reduce the spread of HIV and other infections among them; to efforts to prevent HIV transmission by drug users and others who have recently become infected; and to our understanding of how HIV and other epidemics among people who used drugs do or do not spread to non-users in their communities.
Presented by: Ellen Benoit, PhD & Ian Aronson, PhD
Presentation title: Giving Men a Voice (GMaV) & Revisiting Data to Ask New Questions
Giving Men a Voice (GMaV)
Principal Investigators: Ellen Benoit & Martin Downing
GMaV is a mixed-methods study funded by the NICHD with Black and Latino gay and bisexual men in New York City (N=61) that implemented a trauma-informed approach to assessing formative sexual experiences in childhood (before age 16) with older male and female partners. We also conducted in-depth interviews with 35 service providers in the New York City area, mostly in substance abuse treatment, HIV prevention and treatment and mental health care. Those interviews focused primarily on preparedness to incorporate sexual history and issues of sexuality into treatment or counseling. I will present some of the main findings from the study and briefly describe our plans for the next phase in our research.
Ellen Benoit is a sociologist at North Jersey Community Research Initiative in Newark, NJ. She conducts NIH-funded qualitative and mixed-methods research on health inequality, particularly as it relates to HIV risk and substance use among marginalized groups. With Dr. Liliane Windsor at the University of Illinois, she is a Principal Investigator on a study in Newark using community based participatory research methods and multiphase optimization strategy to test an intervention designed to reduce substance use among formerly incarcerated men. Dr. Benoit is currently a Principal Investigator with Dr. Eric Schrimshaw of the University of Central Florida on a study using sexual script theory to understand the process of sexual socialization and risk behavior in a diverse sample of young men who have sex with men. With Dr. Martin Downing of Lehman College, she is investigating the impact of childhood sexual abuse on adult substance use, health and mental health outcomes among Black and Latino gay and bisexual men. Dr. Benoit is an Associate Director in CDUHR’s Transdisciplinary Research Methods Core.
Revisiting Data to Ask New Questions
Long after study data have been thoroughly examined for primary and exploratory outcomes, existing yet unpublished data may provide valuable opportunities to examine new questions. For example, new findings in an investigator’s own line of research, or in the larger field, may suggest additional directions for data analysis. In this presentation, Dr. Aronson will discuss how analyzing a series of datasets led to new findings about significant relationships between reporting substance use and accepting an HIV test following a computer-based intervention.
Ian David Aronson is a Principal Investigator and Associate Research Scientist in the College of Global Public Health at NYU. He studies how technology-based behavioral health interventions can be developed for clinical and community settings.
Presented by: TBA
Presentation title: TBA
Presented by: Linda M. Collins, PhD
Presentation title: A Brief Introduction to the Multiphase Optimization Strategy (MOST)
Presented by: Vincent Guilamo-Ramos & Holly Hagan
Presentation title: CDUHR Pilot Project Awards Program Information Session
This webinar will help applicants to plan and strategize for a successful pilot proposal. The session will highlight the pilot application process and timeline, answer questions, and end with a discussion of how proposals may fit with the Center’s research mission to address HIV, HCV, and substance use. Awards of up to $25,000 will be funded to support one-year projects addressing emerging research questions.
Click to join:
Access code: 925 093 186
Join by phone:
+1-415-655-0002 US Toll
Vincent Guilamo-Ramos is a professor and Associate Vice Provost of Mentoring and Outreach Programs at New York University (NYU). He is the director and founder of the Center for Latino Adolescent and Family Health. Dr. Guilamo-Ramos also serves as the Pilot and Mentoring Core Director at the Center for Drug Use and HIV Research at the NYU College of Global Public Health. Dr. Guilamo-Ramos is a clinical social worker and nurse practitioner, and is board certified in HIV/AIDS nursing (ACRN) and as a HIV specialist (AAHIVS). Clinically, he has expertise in the primary care of HIV positive adolescents, provision of pre-exposure prophylaxis for high-risk youths, and screening and treatment of sexually transmitted diseases. Dr. Guilamo-Ramos studies the role of families in promoting adolescent health, with a special focus on preventing HIV/AIDS, sexually transmitted infections, unplanned pregnancies, and improving treatment outcomes for HIV positive and at-risk youth. He is a Fellow of the American Academy of Social Work and Social Welfare. He serves as Vice Chair of the Board of Directors for the Latino Commission on AIDS, and is a board member of the Power to Decide. Dr. Guilamo-Ramos received his PhD from SUNY Albany, and his MSW and MPH degrees from NYU. In addition, he holds an MS from the Robert F. Wagner Graduate School of Public Service at NYU and an MSN from the Duke University School of Nursing.
Holly Hagan trained as an infectious disease epidemiologist with an emphasis on methods to study disease causation and control. Her research has addressed the etiology, epidemiology, natural history, prevention and treatment of blood-borne and sexually transmitted infections in key populations in general and among people who use drugs (PWUD) in particular. She is skilled in research synthesis (systematic reviews and meta-analyses) and the methods of implementation science. She has designed and led a number of large observational and experimental studies related to blood-borne viral infections in PWUD, men who have sex with men (MSM), and heterosexuals at high risk of HIV. Dr. Hagan is a member of the WHO Global Burden of Disease Study Diseases and Injuries Group, she served on the Institute of Medicine Committee on the Prevention and Control of Viral Hepatitis in the United States, and have been an advisor to the US Department of Health and Human Services, the CDC, and the Canadian Institutes of Health on national programs to detect, diagnose and treat HCV infections.
Presented by: Victoria Frye, DrPH
Presentation title: TRUST: A Friend-based Intervention to Increase Consistent HIV Self-testing among Black or African-American, Gay, Bisexual and Other MSM and Transgender Women
Dr. Frye will describe the design and preliminary results of TRUST, a randomized controlled trial of an intervention designed to support consistent HIV self-testing among Black or African-American MSM and transgender women. TRUST randomized friend pairs to either a brief behavioral intervention, where they learned how to HIV self-test, enhanced peer support for testing and linkage to care, and increased motivation and developed plans for consistent testing (every three months), or a control condition, where they learned about self-screening for a range of common health conditions. This talk will describe the original vision for the intervention, changes made along the way in the study design and preliminary results of impact of the intervention on HIV self-testing at 3, 6, 9 and 12 months post-intervention.
Victoria Frye is an Associate Medical Professor in the Department of Community Health and Social Medicine of the CUNY School of Medicine (CSOM). She received her BA (History), MPH (Epidemiology) and DrPH (Sociomedical Sciences) from Columbia University. Dr. Frye is currently the Principal Investigator of two HIV prevention studies funded by the NIH. PEPTALK (R21 AI-122996) is a study to design and evaluate a media campaign to increase demand for post-exposure HIV prophylaxis (PEP), among gay, bisexual and other men who have sex with men (MSM). TRUST (R01 DA-038108) is a randomized, controlled trial (RCT) to test a peer-based behavioral intervention to increase consistent HIV self-testing among African-American or Black MSM and transgender women.
Presented by: Eli Rosenberg, PhD
Presentation title: HCV/HIV Prevalence, Risk, and Care among Persons Who Inject Drugs in Upstate New York
Dr. Rosenberg will review recent work to describe the epidemiology of HCV infection in New York State, centered on the New York Hepatitis C Elimination Initiative. He will discuss emerging findings from the Upstate PWID Study for Infectious Disease Elimination (UPSIDE), an HCV/HIV bio-behavioral survey of persons who inject drugs in 3 upstate New York communities, and implications for future research and surveillance activities.
Eli Rosenberg, PhD, is an associate professor in the Department of Epidemiology and Biostatistics at the University at Albany School of Public Health, SUNY. His research centers on applied and analytic epidemiologic studies that address current public health challenges in HIV, STI, and viral hepatitis surveillance, prevention, and social determinants, with a focus on persons who inject drugs and men who have sex with men.